GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/How Do We Get More People Screened for Colorectal Cancer: Gastroenterology| September 2026
7

How Do We Get More People Screened for Colorectal Cancer: Gastroenterology| September 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2026

Introduction:

CRC screening reduces incidence and mortality, yet participation remains suboptimal. This network meta-analysis of 76 randomized trials compared strategies for improving screening uptake.

Why was this study needed?

Screening only works when patients complete it.

Access, logistics, awareness and fear remain major barriers.

The most effective outreach strategy remains uncertain.

Which Strategies Worked Best?

Two approaches performed best:

  1. Patient navigation: Actively helping patients overcome barriers produced the greatest improvement.

  2. Mailed FIT: Sending FIT directly to patients was highly effective and scalable.

Navigation also outperformed simple reminders, showing that helping patients complete screening matters more than simply recommending it.

What About Reminders and Education?

Educational multimedia and reminders produced more modest benefits. Digital education appeared more useful in populations with higher baseline screening uptake.

Mailed FIT vs Colonoscopy Outreach

Mailed FIT was more effective than direct colonoscopy outreach for increasing participation.

This does not mean FIT is a better test—it means convenient home-based screening reduces barriers to completion.

Baseline Screening Uptake Matters

Where baseline screening was <30%, mailed FIT more than tripled participation, making it particularly attractive for underserved populations.

Clinical and Public Health Implication:

Screening programs should move from:

Recommend screening → wait

to:

Identify → actively reach out → provide easy screening → navigate positive FIT to colonoscopy

Caution:

Most studies assessed short-term completion. FIT programs still require repeated testing and colonoscopy after a positive result.

Bottom Line:

Patient navigation and mailed FIT are the most effective strategies for increasing CRC screening uptake, particularly mailed FIT in low-participation populations. Making screening easy to access and complete is key.

Related Q&A

08

High-Dose Vitamin D3 Fails to Improve Outcomes in Metastatic Colorectal Cancer (Phase III SOLARIS Trial): JAMA | September 2026

Introduction: Vitamin D has long attracted interest as a potential adjunctive treatment in colorectal cancer. Preclinical studies demonstrate antiproliferative, pro-differentiation, anti-inflammatory and immunomodulatory effects, while observational studies have...

09

Probiotics After Rifaximin May Reduce Relapse in IBS-D: JGH | August 2026

Introduction: Rifaximin can improve symptoms in diarrhoea-predominant irritable bowel syndrome (IBS-D), but relapse after treatment remains common. Because rifaximin alters the intestinal microbial environment, post-treatment microbiome modulation may...

10

Vancomycin Taper vs Fidaxomicin for Recurrent C. difficile Infection (OpTION Trial): NEJM Evidence | August 2026

Introduction: Recurrent Clostridioides difficile infection (CDI) remains a major clinical challenge, with recurrence occurring in up to one-third of patients after initial treatment. Although both vancomycin taper-and-pulse (VAN-TP)...

11

DPP-4 Inhibition targeting the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Increasing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This preclinical study investigated...

12

Adjuvant Aspirin in Colorectal Cancer: The Lancet Gastroenterology & Hepatology | July 2026

Introduction: Although aspirin has long been investigated as adjuvant therapy for colorectal cancer (CRC), the overall ASCOLT trial showed no improvement in disease-free survival (DFS). This translational analysis...

13

Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026

Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer